Alvogen launched the generic equivalent of Mestinon (pyridostigmine bromide ER). The Alvogen item will be added to the OneStop program in
the A* slot, with visibility in McKesson Connect Tuesday, June 30, 2015.
Estimated U.S. brand sales of Mestinon are approximately $35M.
Brand Item:
| Item # |
NDC |
Description |
| 1101567 |
00187301330 |
MESTINON TMSPAN TB 180MG 30 |
There will not be an ASAP/ASAP+ for this launch.
| Product Launch Information – OneStop Add |
| Bx Name |
Mestinon |
| Bx Supplier |
Valeant (formerly Salix) |
| Generic Name |
pyridostigmine bromide ER |
| Generic Description |
pyridostig ER tab 180mg alv30 |
| Therapeutic Class/Indication |
Pyridostigmine is used to improve muscle strength in patients with a certain muscle disease (myasthenia gravis). It works by preventing the breakdown of a certain natural substance (acetylcholine) in your body. Acetylcholine is needed for normal muscle function. |
| FDA Approval Date |
6/29/2015 |
| Launch Reason |
FDA Approval |
| Launch Exclusivity |
Yes |
| Number of Players |
1 |
| US Brand Sales |
$35M |
To order, please use the following item numbers:
| Item # |
Supplier Name |
NDC |
Description |
OS ADD |
| 3465838 |
ALVOGEN INC |
47781033530 |
PYRIDOSTIG ER TAB 180MG ALV30 |
06/30/2015 |
For questions please contact ISManagement@McKesson.com.